Journal ArticleDOI
Targeting Free Radicals in Oxidative Stress-Related Human Diseases.
Patrik Poprac,Klaudia Jomová,Miriama Simunkova,Vojtech Kollar,Christopher J. Rhodes,Marian Valko +5 more
Reads0
Chats0
TLDR
Metal chelation, based on the application of selective metal chelators or metal delivery, may induce neuroprotective signaling and represents a promising therapeutic strategy in cancer and AD.Citations
More filters
Journal ArticleDOI
Cholinesterase Inhibitors in Alzheimer's Disease
TL;DR: Data indicate that aminoacridines, as a class of compounds, have a statistically significant effect to diminish, slightly, some of the cognitive symptoms of Alzheimer's Disease, and encourage the use of drugs that will reverse multiple neurotransmitter deficits.
Journal ArticleDOI
Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases.
Mehdi Sharifi-Rad,Nanjangud V. Anil Kumar,Paolo Zucca,Elena Maria Varoni,Luciana Dini,Elisa Panzarini,Jovana Rajkovic,Patrick Valere Tsouh Fokou,Elena Azzini,Ilaria Peluso,Abhay Prakash Mishra,Manisha Nigam,Youssef El Rayess,Marc El Beyrouthy,Letizia Polito,Marcello Iriti,Natália Martins,Miquel Martorell,Anca Oana Docea,William N. Setzer,Daniela Calina,William C. Cho,Javad Sharifi-Rad +22 more
TL;DR: The diseases in which oxidative stress is one of the triggers and the plant-derived antioxidant compounds with their mechanisms of antioxidant defenses that can help in the prevention of these diseases are discussed.
Journal ArticleDOI
Bioactive compounds and bioactivities of ginger (zingiber officinale roscoe)
TL;DR: It is hoped that this updated review paper will attract more attention to ginger and its further applications, including its potential to be developed into functional foods or nutraceuticals for the prevention and management of chronic diseases.
Journal ArticleDOI
Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications.
Qingzheng Kang,Chunxue Yang +1 more
TL;DR: The abnormalities correlated with oxidative stress provide multiple potential therapeutic targets to develop safe and effective treatments for diabetic retinopathy and are summarized.
Journal ArticleDOI
Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases
TL;DR: Understanding the spatiotemporal availability of iron and the role of iron in generating ROS will provide clues for the suppression of ROS and cytotoxic redox-active iron and enable us to find novel therapeutic targets for various diseases.
References
More filters
Journal ArticleDOI
CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth
Takatsugu Ishimoto,Osamu Nagano,Toshifumi Yae,Mayumi Tamada,Takeshi Motohara,Hiroko Oshima,Masanobu Oshima,Tatsuya Ikeda,Rika Asaba,Hideki Yagi,Takashi Masuko,Takatsune Shimizu,Tomoki Ishikawa,Tomoki Ishikawa,Kazuharu Kai,Eri Takahashi,Yu Imamura,Yoshifumi Baba,Mitsuyo Ohmura,Makoto Suematsu,Hideo Baba,Hideyuki Saya +21 more
TL;DR: It is shown that a CD44 variant (CD44v) interacts with xCT, a glutamate-cystine transporter, and controls the intracellular level of reduced glutathione (GSH).
Journal ArticleDOI
The pentose phosphate pathway and cancer.
TL;DR: The PPP plays a pivotal role in helping glycolytic cancer cells to meet their anabolic demands and combat oxidative stress, and its importance in cancer cell metabolism and survival is summarized.
Journal ArticleDOI
Does vitamin C act as a pro-oxidant under physiological conditions?
Anitra C. Carr,Balz Frei +1 more
TL;DR: Although the data on protein oxidation in humans are sparse and inconclusive, the available data in animals consistently show an antioxidant role of vitamin C, both in the presence and absence of metal ions.
Journal ArticleDOI
Hsp90 molecular chaperone inhibitors: are we there yet?
Len Neckers,Paul Workman +1 more
TL;DR: Success will likely lie in treating cancers that are addicted to particular driver oncogene products that are sensitive Hsp90 clients, as well as malignancies in which buffering of proteotoxic stress is critical for survival.
Journal ArticleDOI
FDA-approved small-molecule kinase inhibitors
TL;DR: All approved small-molecule kinase inhibitors with an emphasis on binding mechanism and structural features are presented, current challenges are summarized, and future directions in this field are discussed.